Client News

Endpoint Health Launches out of Stealth

Join us in congratulating ENDPOINT HEALTH. Launching out of stealth today, this H+C client is the first company founded to develop targeted therapeutics for #criticalillnesses including #sepsis, #ARDS and #COVID19. Katie Jennings at Forbes has the exclusive, read more here: https://bit.ly/2OmcIJ6.

View Post
Client News

Congratulations to January.ai on Data Presented at ADA

Congratulations to the team at January.ai on data presented at the American Diabetes Association Scientific Sessions in support of their new, personalized program for people with diabetes! More to explore here: https://lnkd.in/ga8vEVm #ADA2020 #Diabetes

View Post
Client News

Sarepta’s Gene Therapy Improved Muscle Function

A great way to start off our week 👏 Today, H+C client Sarepta Therapeutics announced positive clinical results from its investigational #genetherapy for the treatment of #limbgirdle #musculardystrophy Type 2E, one of the many subtypes of LGMD

View Post
Client News

Remembering Michael Seres

We were so inspired by the vision, passion and sense of humor of Michael Seres, founder and CEO of 11 Health. His enthusiasm to make a difference was infectious, and

View Post
Client News

Argenx Announces Results of Phase 3 Clinical Trial

Cheers to H+C client argenx for announcing results of their first Phase 3 clinical trial. 👏 Positive results demonstrated significant improvements in the daily living activities of certain patients living with

View Post
Client News

Free Virtual Patient Support Program

Great news from 11 Health. As #COVID19 pervades nearly every corner of the healthcare landscape, it’s great to see companies using #remotemonitoring technology and #peersupport to help keep vulnerable patient

View Post
Follow us on instagram
@healthandcommerce